Cargando…

PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma

BACKGROUND: Overexpression of PTK7 has been found in multiple cancers and has been proposed to serve as a prognostic marker for intrahepatic cholangiocarcinoma. Its role in esophageal cancer, however, remains to be clarified. We hypothesize that PTK7 positively regulates tumorigenesis of esophageal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kang, Song, Guiqin, Zhang, Xuqian, Li, Qiujiang, Zhao, Yunxia, Zhou, Yuchuan, Xiong, Rong, Hu, Xin, Tang, Zhirong, Feng, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445388/ https://www.ncbi.nlm.nih.gov/pubmed/28545451 http://dx.doi.org/10.1186/s12957-017-1172-x

Ejemplares similares

SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB
por: Song, Guiqin, et al.
Publicado: (2017)

Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma
por: Shin, Won-Sik, et al.
Publicado: (2018)

ENST00000489707.5 Is a Preferred Alternative Splicing Variant of PTK7 in Adrenocortical Cancer and Shows Potential Prognostic Value
por: Bie, Jun, et al.
Publicado: (2019)

PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells
por: Shin, Won-Sik, et al.
Publicado: (2022)

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022)

Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
por: Kim, Jae Hoon, et al.
Publicado: (2022)

LINC01305 recruits basonuclin 1 to act on G‐protein pathway suppressor 1 to promote esophageal squamous cell carcinoma
por: Xiong, Li, et al.
Publicado: (2023)

PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
por: Wozniak, Darren J., et al.
Publicado: (2017)

Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling
por: Shin, Won-Sik, et al.
Publicado: (2023)

PTK7 Faces the Wnt in Development and Disease
por: Berger, Hanna, et al.
Publicado: (2017)

Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β-catenin pathway
por: Xiang, Xiaocong, et al.
Publicado: (2019)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
por: Liu, Xue-Kui, et al.
Publicado: (2013)

Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
por: Qiu, Luping, et al.
Publicado: (2018)

JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Liu, Honggang, et al.
Publicado: (2023)

FSCN1 Promotes Esophageal Carcinoma Progression Through Downregulating PTK6 via its RNA-Binding Protein Effect
por: Cai, Hongfei, et al.
Publicado: (2022)

Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis
por: Ye, Bo, et al.
Publicado: (2021)

Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell Carcinoma
por: Sun, Xiujing, et al.
Publicado: (2013)

Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma
por: He, Xiaoyan, et al.
Publicado: (2015)

Ptk7 Marks the First Human Developmental EMT In Vitro
por: Chan, David N., et al.
Publicado: (2012)

Variants identified in PTK7 associated with neural tube defects
por: Lei, Yunping, et al.
Publicado: (2019)

PTK-7 Expression in Gastric Cancer: A Prognostic Determinant
por: Özçelik, Melike, et al.
Publicado: (2020)

PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
por: Jie, Yamin, et al.
Publicado: (2021)

Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells
por: Shin, Won-Sik, et al.
Publicado: (2016)

Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC)
por: Song, Guiqin, et al.
Publicado: (2019)

HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma
por: Wu, Xiang, et al.
Publicado: (2021)

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate
por: Xiang, Wei, et al.
Publicado: (2022)

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
por: Gavine, Paul R., et al.
Publicado: (2015)

PBF, a Proto-oncogene in Esophageal Carcinoma
por: Lian, Shi-hai, et al.
Publicado: (2019)

SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas
por: Bass, Adam J., et al.
Publicado: (2009)

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
por: Cao, Yu-Fei, et al.
Publicado: (2022)

PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance
por: Tian, Xiuyun, et al.
Publicado: (2016)

The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer
por: Sun, Jun-Jie, et al.
Publicado: (2019)

The Mutational Landscape of PTK7 in Congenital Scoliosis and Adolescent Idiopathic Scoliosis
por: Su, Zhe, et al.
Publicado: (2021)

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023)

Kinetochore microtubules in PTK cells
Publicado: (1992)

Repeated phototherapeutic keratectomy (PTK) followed by PTK with photorefractive keratectomy for anterior granular corneal dystrophy
por: Sridhar, Uma, et al.
Publicado: (2020)

PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression
por: Lang, Yaw-Dong, et al.
Publicado: (2019)

Engrailed-2 promotes a malignant phenotype of esophageal squamous cell carcinoma through upregulating the expression of pro-oncogenic genes
por: Cao, Yong, et al.
Publicado: (2020)

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
por: Qin, Hui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2nob2h9hl1tc2ms307h9hjamp3